303 results
Page 5 of 16
6-K
EX-99.1
n2wsbcpxbij7 2z9vw0q
15 Jun 22
Pfizer and BioNTech Provide Update on Rolling Submission to European Medicines Agency for a Potential Variant-Adapted Vaccine
6:13pm
6-K
EX-99.2
yof0jm2ffxhp9nbk9xm
1 Jun 22
Voting Results from BioNTech’s Annual General Meeting 2022
7:01pm
6-K
EX-99.1
s60jas2pez7 zk
23 May 22
Current report (foreign)
8:48am
6-K
EX-99.1
6kmqou9ldyz0ynx
17 May 22
Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age
5:13pm
6-K
EX-99.1
lud3ezcm19brerbvesev
16 May 22
Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission
7:48am
6-K
EX-99.1
tl8iw w0967nt54v
12 May 22
Current report (foreign)
5:18pm
6-K
EX-99.1
p4yg15jgv
9 May 22
Unaudited Interim Condensed Consolidated Financial Statements
7:05am
6-K
EX-99.1
7wcu1xneohs3c4r2e
9 May 22
BioNTech Announces First Quarter Financial Results and Corporate Update
12:00am
6-K
EX-99.2
hwbx9bgcjgq5 hchpjxb
9 May 22
BioNTech Announces First Quarter Financial Results and Corporate Update
12:00am
6-K
EX-99.1
u3y238j0trfxga 9m0vk
26 Apr 22
Current report (foreign)
5:11pm
6-K
EX-99.1
iqttt9br39714rt3
14 Apr 22
Current report (foreign)
8:57am
6-K
EX-99.1
ytmbaka1zb2pd0 des
11 Apr 22
BioNTech Granted Pandemic Preparedness Contract by German Federal Ministry of Health
8:11am
6-K
EX-99.2
9516l73f
30 Mar 22
BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
7:24am
6-K
EX-99.1
rloa eq7ge8rzm97tb
30 Mar 22
BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
7:24am
6-K
EX-99.1
nmfdz2n0 4kb
29 Mar 22
Current report (foreign)
4:40pm